UAE IVF Drugs and Food Supplements Market, by Product Type (Drugs (Clomiphene, Injectable Hormones (Human chorionic gonadotropin (hCG), Follicle-stimulating hormone (FSH), Human menopausal gonadotropin (hMG), Gonadotropin-releasing hormone (GnRH), GnRH agonist, and GonGnRH antagonist), and Food Supplements), and by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), is estimated to be valued at US$ 20.4 Mn in 2022 and is expected to exhibit a CAGR of 6.6% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Research and development for fertility issues by research institutes, government authorities are focused on expanding the UAE IVF drugs and food supplements market through product developments, in order to meet escalating demand for treatment of fertility issues is expected to boost the market growth. For instance, on September 8, 2021, Omnia Health, suppliers of healthcare products and services stated that several studies, including those published by the Global Diabetes Community, and has shown a direct and indirect link between diabetes and obesity on both male and female infertility. Moreover, based on Collier's research and interviews with industry experts, compared to 10% worldwide, the infertility rate in the region is 15% or even higher. Infertility is split approximately 50% male to female across the Middle East region. Furthermore, the growth in the UAE IVF sector stems not only from domestic demand but also from the success of the UAE, particularly Dubai, in promoting medical tourism and the availability of infertility treatment centers, which are of international standards.
UAE IVF Drugs and Food Supplements Market– Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic, which was initially detected on December 31, 2019, in Wuhan, China. COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. According to the World Health Organization's Coronavirus Illness (COVID-19) Weekly Epidemiological Update, coronavirus disease (COVID-19) caused approximately 18 million cases and 321,124 fatalities in the UAE between January 24, 2021 and January 30, 2022.
Furthermore, IVF activity took a hit at the beginning of the pandemic. Embryo transfers slowed as the sector awaited guidelines from the Dubai Health Authority (DHA). To restart the embryo transfer, clinics adopted COVID-safe protocols. Fertility clinics, as with much of the healthcare industry, increasingly turned to telehealth in 2020 which helped patient to follow up the procedure of IVF treatment and getting help for guidance for food supplements and drugs required for improving the fertility chances. As the telehealth option were available for patients is reduced the chances of COVID-19 infection for patients undergoing IVF treatment as the hospital visit reduced due to consulting through telehealth option were available.
Browse 38 Market Data Tables and 42 Figures spread through 198 Pages and in-depth TOC on “IVF Drugs and Food Supplements Market”- UAE Forecast to 2030, UAE IVF Drugs and Food Supplements Market, by Product Type (Drugs (Clomiphene, Injectable Hormones (Human chorionic gonadotropin (hCG), Follicle-stimulating hormone (FSH), Human menopausal gonadotropin (hMG),Gonadotropin-releasing hormone (GnRH), GnRH agonist, and GonGnRH antagonist), and Food Supplements), and by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies)
To know the latest trends and insights prevalent in the UAE IVF Drugs and Food Supplements Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/uae-ivf-drugs-and-food-supplements-market-4939
Moreover, the government initiative for providing healthcare services and funding to market players to provide healthcare services is expected to drive growth of UAE IVF drugs and food supplements market over the forecast period. For instance, in July 2020, The Medical Office of the Ministry of Presidential Affairs (MOPA) expanded the quantity and quality of healthcare provision in the U.A.E., particularly in the northern emirates. Moreover, MOPA funded the US$ 204 million to Sheikh Khalifa General Hospital in Umm Al Quwain, which featured clinics specializing in pediatrics, gynecology, emergency care, dialysis, and others. MOPA also funded the US$ 272 million to Sheikh Khalifa Specialty Hospital, the Follow-Up Committee of the Initiatives of the U.A.E. President approved funding for the Khalifa Central Hospital in Fujairah at a cost of US$ 236 million.
Key Takeaways of the UAE IVF Drugs and Food Supplements Market:
- UAE IVF drugs and food supplements market is expected to exhibit a CAGR of 6.6% during the forecast period owing to assisted guidelines for reproductive technology treatment by government authorities to avoid risk factor during treatment is expected to support growth of the market during the forecast period. For instance, in 2019, The Department of Health– Abu Dhabi (DOH) which stated about the Rate of severe complications resulting from fertility treatment to avoid such instance DOH provided possible solution for complications which is expected to reduce the risk during IVF treatment.
- Major players operating in the UAE IVF drugs and food supplements market include Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KGaA, and Ferring B.V.
